Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ABIO Stock Annual Income Statement. Download in Excel

ARCA biopharma Inc. logo

ARCA biopharma Inc.

Sector: Healthcare   

Industry: Biotechnology

2.40
 
USD
  
0.00
  
(0.00%)
Previous close: 2.4  Open: 2.35  Bid:   Ask:
52 week range    
1.56   
   4.49
Mkt Cap: 56 M  Avg Vol (90 Days): 0
Peers   
CYTK / 
PTN / 
BTX / 
MDT / 
Last updated: Friday 6th December 2024

Stock Rankings

21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

ABIO Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-2.07-1.39-0.69-0.37
Basic EPS total-2.07-1.39-0.69-0.37
Basic weighted shares outstanding1 M349405.0503746.0579521.0769391.01 M5 M14 M14 M14 M
Depreciation8000.016000.020000.015000.0
Depreciation unreconciled-12000.0-19000.0-24000.0-27000.0-22000.0-18000.0
DepreciationAndAmortization-12000.0-19000.0-24000.0-27000.0-22000.0-18000.08000.016000.020000.015000.0
Diluted EPS total-8.46-32.76-32.58-31.86-10.26-4.15-2.07-1.39-0.69-0.37
Diluted normalized net income/share-4.15-0.69-0.37
Diluted weighted shares outstanding1 M349359.0504726.0580351.0773196.01 M5 M14 M14 M14 M
GeneralAndAdministrativeExpense4 M4 M4 M5 M4 M4 M5 M6 M6 M6 M
Income before tax-10 M-11 M-16 M-19 M-8 M-6 M-10 M-19 M-10 M-5 M
Income restructuring and M&A159000.0
Income taxes-1 M-188000.0-137000.0-61000.0-31000.0-167000.0-9000.0-695000.0-357000.0-192000.0
Interest income7000.014000.0169000.0167000.0162000.0172000.028000.013000.0675000.02 M
InterestExpenseNonOperating3000.04000.06000.08000.07000.09000.0
MiscOtherSpecialCharges-5000.0
Net income from total operations-10 M-11 M-16 M-18 M-8 M-5 M-10 M-19 M-10 M-5 M
NetIncomeCommonStockholders-10 M-11 M-16 M-18 M-8 M-5 M-10 M-19 M-10 M-5 M
NetIncomeContinuousOperations-10 M-11 M-16 M-18 M-8 M-5 M-10 M-19 M-10 M-5 M
NetNonOperatingInterestIncomeExpense4000.010000.0169000.0161000.0154000.0165000.019000.013000.0675000.02 M
Normalized income-5 M
Operating income-10 M-11 M-17 M-19 M-8 M-6 M-10 M-19 M-11 M-7 M
Operating income before depreciation (EBITDA)-10 M-11 M-16 M-18 M-8 M-6 M-10 M-19 M-10 M-7 M
OperatingExpense-10 M-11 M-17 M-19 M-8 M6 M10 M19 M11 M7 M
Other income net5000.0
OtherGandA4 M4 M4 M5 M4 M4 M5 M6 M6 M6 M
RentAndLandingFees4 M4 M4 M5 M4 M
Research & development expense6 M7 M12 M14 M4 M2 M5 M14 M5 M1 M
ResearchExpense6 M7 M12 M14 M4 M2 M5 M14 M5 M1 M
RestructringAndMnAIncome159000.0
SalariesAndWages-647000.0-599000.0-576000.0-458000.0-273000.0-151000.0
Selling Gen & administrative expense4 M4 M4 M5 M4 M4 M5 M6 M6 M6 M
Special income/charges-159000.0
Total Income available for interest expense (EBIT)-10 M-11 M-16 M-19 M-8 M-6 M-10 M-19 M-11 M-7 M
Total common shares outstanding168241.0503147.0507273.0773017.01 M2 M14 M14 M14 M15 M
Total net income-10 M-11 M-16 M-18 M-8 M-5 M-10 M-19 M-10 M-5 M
Total ordinary shares15 M15 M15 M15 M15 M15 M15 M15 M15 M15 M
TotalExpenses-10 M-11 M-17 M-19 M-8 M6 M10 M19 M11 M7 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University